v3.26.1
STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)
 3 Months Ended 12 Months Ended
Nov. 01, 2024
Sep. 15, 2023
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Mar. 20, 2026
Jul. 02, 2023
Mar. 02, 2023
Shares issued               2,000,000
Common stock price per share               $ 0.42
Warrants receivable             3,250,000  
Warrants per share             $ 0.001  
Warrants issued shares   500,000            
Consulting expenses   $ 602,179            
Warrants issued 800,000   277,778          
Value of warrants issued $ 215,962              
Derivative, Loss on Derivative     $ 7,415          
Issued shares of stock exercised       1,991,930        
Issued shares of stock exercised, value       $ 28,987        
Issued shares for services     117,000 125,000        
Issued shares for services, value     $ 23,400 $ 47,500        
Issued shares for convertible debentures     11,327,804 4,961,709        
Issued shares for convertible debentures, value     $ 121,178 $ 961,193        
Shares issued, value     $ 137,192          
Shares issued     29,047,900          
Equity Purtchase Agreement [Member]                
Maximum purchase amount           $ 30,000,000    
Commitment shares           3,000,000,000,000    
Stock Price Guarantee Arrangement [Member]                
Shares issued, value     $ 15,325          
Shares issued     250,000          
Common Stock [Member]                
Issued shares for convertible debentures     19,404,168          
Series D Preferred Stock [Member]                
Issued shares for convertible debentures     1,940,417          
Warrant [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted     1,466,666   277,778